Concord Biotech receives GMP certificate from Kenya regulator
Drug Approval

Concord Biotech receives GMP certificate from Kenya regulator

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series

  • By IPP Bureau | February 26, 2024

The Ministry of Health Pharmacy and Poisons Board, Republic of Kenya had conducted inspection of Unit II (formulation facility) of Concord Biotech Limited, located at Valthera-Dholka (Unit II) in Ahmedabad, Gujarat.

The said inspection has been completed successfully, without any adverse remarks and the company has received the certificate of Good manufacturing practices (GMP) as on today (i.e. 22nd February, 2024).

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series and other internationally acceptable guidelines.

Upcoming E-conference

Other Related stories

Startup

Digitization